CBD in Cosmetics — A Skincare Breakthrough or Marketing Hype?

CBD — from controversy to cosmetic darling

Cannabidiol (CBD) is one of more than 100 cannabinoids found in hemp (Cannabis sativa). Unlike THC, it has no psychoactive effect, which opened the door for it into the wellness and cosmetics industry. Over the past few years, CBD has become one of the trendiest ingredients in skincare — from creams to lip balms.

But popularity is not the same as efficacy. Let's take a closer look at what we know, what we don't, and where the marketing runs ahead of the science.

How it works — the skin's endocannabinoid system

The skin has its own endocannabinoid system (ECS), with CB1 and CB2 receptors as well as TRPV1 and PPAR-gamma receptors. CBD can act on these receptors, influencing:

• Sebum production — in vitro studies from 2014 (Journal of Clinical Investigation) showed that CBD inhibits lipogenesis in human sebocytes, suggesting potential in treating acne.
• Inflammatory processes — CBD has anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines (TNF-alpha, IL-6).
• Keratinocyte proliferation — preliminary data suggest possible applications in psoriasis, although clinical research is very limited.

This sounds promising, but one key caveat must be emphasised: most of this data comes from in vitro studies or animal models. Moving from an effect in a test tube to efficacy on human skin is a long road.

The state of clinical evidence — what do we actually know?

As of 2026, we have only a limited number of well-designed clinical trials on the topical use of CBD:

• Acne — several small studies (20–40 participants) show a moderate reduction in inflammation and sebum production. The results are promising, but far from conclusive.
• Atopic dermatitis (eczema) — one 2019 pilot study found improved hydration and reduced itching. The lack of a placebo control limits the value of these findings.
• Skin ageing — CBD's antioxidant properties have been confirmed in vitro, but there are no clinical studies confirming an anti-ageing effect when applied to the skin.
• Pain and inflammation — here the evidence is strongest in the context of transdermal formulations (those that penetrate the skin), but this relates more to medical than cosmetic applications.

Check the PurScore ingredient database to see how CBD (Cannabidiol) is classified in products available on the market.

EU regulations — a legal maze

The legal status of CBD in cosmetics within the European Union is complex and evolving:

• CosIng — the European Commission's cosmetic ingredient database classifies Cannabidiol as a permitted cosmetic ingredient, provided it is derived from synthesis or from parts of the hemp plant permitted in the EU.
• Novel Food vs. cosmetics — "novel food" regulations do not apply directly to cosmetics, but they do affect the availability of CBD raw materials on the market.
• THC — cosmetic products may not contain THC above trace amounts (the limit varies from country to country).
• Concentrations — there is no harmonised limit on CBD concentration in cosmetics. Manufacturers use anywhere from 0.01% to 5%, and the differences in efficacy at these concentrations have not been established.

Marketing vs. reality — what to watch out for

The CBD cosmetics market is unfortunately full of marketing abuses. Here are the most common traps:

1. "Hemp oil" is not CBD — hemp seed oil (Cannabis Sativa Seed Oil) is a completely different ingredient from CBD. It is rich in fatty acids but contains no cannabinoids. Many "hemp" products do not contain a single milligram of CBD.
2. No information on concentration — if a manufacturer does not state the CBD concentration, it is probably negligible and biologically insignificant.
3. "Full-spectrum" extract — this may contain minimal amounts of THC and other cannabinoids. It's not a health concern, but it's worth knowing what you're applying to your skin.
4. Price — CBD is expensive to source, so a CBD cream for the equivalent of a few euros probably contains only marginal amounts of the ingredient.

Compare CBD products using the PurScore search engine to see which ones actually declare meaningful concentrations.

Skin penetration — does CBD in a cream even absorb?

This is a fundamental question that marketing is happy to skip over. CBD is a lipophilic molecule with a relatively large molecular mass (314 g/mol). This means that:

• It penetrates the stratum corneum of the epidermis only to a limited degree.
• It may accumulate in the epidermis and dermis, but penetration into deeper layers is limited.
• The cosmetic formulation matters enormously — lipid carriers, liposomes and nanoemulsions can significantly improve absorption.

That's why simply adding CBD to a cream is not enough — the delivery technology is key. Cheap CBD products in a basic cream base may have marginal bioavailability.

Safety — is there any cause for concern?

CBD used topically is generally well tolerated. Its safety profile looks favourable:

• Low risk of irritation and allergies.
• No psychoactive effect when applied to the skin.
• No known interactions with cosmetic ingredients.

The only risk concerns the quality of the raw material — low-quality CBD may contain contaminants (pesticides, heavy metals, solvents). You can read more about assessing ingredient quality in our guide to natural and synthetic ingredients.

Conclusion — promising, but immature

CBD in cosmetics is an ingredient with genuine scientific potential, but in 2026 we are still at the stage of "promising preliminary data". The main problems are:

• An insufficient number of large clinical trials.
• A lack of standardisation in concentrations and delivery forms.
• A huge gap between marketing messaging and the current state of knowledge.

Is it worth trying? If you have skin prone to inflammation and you find a product from a reputable manufacturer with a clearly stated CBD concentration, it may turn out to be a valuable ingredient. But don't expect the miraculous transformation promised on Instagram.